Review



dna engine chromo4 system bio rad lab  (Bio-Rad)


Bioz Verified Symbol Bio-Rad is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    Bio-Rad dna engine chromo4 system bio rad lab
    UGT1A1 gene polymorphism on telmisartan, irinotecan, dolutegavir, latermovir, axitinib pharmacokinetic parameter.
    Dna Engine Chromo4 System Bio Rad Lab, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 99/100, based on 2758 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dna+engine+chromo4+system+bio+rad+lab/DNA+Engine/pmc09798452-13-9-13
    Average 99 stars, based on 2758 article reviews
    dna engine chromo4 system bio rad lab - by Bioz Stars, 2026-09
    99/100 stars

    Images

    1) Product Images from "Transporter and metabolizer gene polymorphisms affect fluoroquinolone pharmacokinetic parameters"

    Article Title: Transporter and metabolizer gene polymorphisms affect fluoroquinolone pharmacokinetic parameters

    Journal: Frontiers in Pharmacology

    doi: 10.3389/fphar.2022.1063413

    UGT1A1 gene polymorphism on telmisartan, irinotecan, dolutegavir, latermovir, axitinib pharmacokinetic parameter.
    Figure Legend Snippet: UGT1A1 gene polymorphism on telmisartan, irinotecan, dolutegavir, latermovir, axitinib pharmacokinetic parameter.

    Techniques Used: Mass Spectrometry, Bioprocessing, Infection, Sequencing, Clinical Proteomics

    Related Articles

    Polymerase Chain Reaction:

    Article Title: Transporter and metabolizer gene polymorphisms affect fluoroquinolone pharmacokinetic parameters
    Article Snippet: rs4124874 , Matrix-Assisted Laser Disorption/Ionization Time-of Flight Mass Spectrometry , 58 , Chinese , Hypertension , Telmisartan , Affected telmisartan bioavailability, Lower creatinine clearance and higher bioavailability in female with CC and CA genotype (high triglyceride) , . .. *28 , Real-Time Allelic Discrimination PCR Assays on a DNA Engine Chromo4 System Bio-Rad Lab, United States) , 93 , European , HIV , Dolutegravir , Homozygosity was associated with a 79% increase in AUC 0-24 ( p = 0.001; 27% if analyzed individually , . .. rs4148323 , BioProcessing Solutions Alliance in Piscat-away, New Jersey , 296 , Asian, Black, White & Other , Prevention CMV Infection , Letermovir , An allele was present predominantly in Asian participants and was associated with an increase in AUC compared with non-carriers , .



    Similar Products

    dna engine chromo4 system bio rad lab  (Bio-Rad)
    99
    Bio-Rad dna engine chromo4 system bio rad lab
    UGT1A1 gene polymorphism on telmisartan, irinotecan, dolutegavir, latermovir, axitinib pharmacokinetic parameter.
    Dna Engine Chromo4 System Bio Rad Lab, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dna+engine+chromo4+system+bio+rad+lab/DNA+Engine/pmc09798452-13-9-13
    Average 99 stars, based on 1 article reviews
    dna engine chromo4 system bio rad lab - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    UGT1A1 gene polymorphism on telmisartan, irinotecan, dolutegavir, latermovir, axitinib pharmacokinetic parameter.

    Journal: Frontiers in Pharmacology

    Article Title: Transporter and metabolizer gene polymorphisms affect fluoroquinolone pharmacokinetic parameters

    doi: 10.3389/fphar.2022.1063413

    Figure Lengend Snippet: UGT1A1 gene polymorphism on telmisartan, irinotecan, dolutegavir, latermovir, axitinib pharmacokinetic parameter.

    Article Snippet: *28 , Real-Time Allelic Discrimination PCR Assays on a DNA Engine Chromo4 System Bio-Rad Lab, United States) , 93 , European , HIV , Dolutegravir , Homozygosity was associated with a 79% increase in AUC 0-24 ( p = 0.001; 27% if analyzed individually , .

    Techniques: Mass Spectrometry, Bioprocessing, Infection, Sequencing, Clinical Proteomics